Modulation of neutrophil adhesion to vascular endothelial cells in rat experimental otitis media treated with a macrolide

Auris Nasus Larynx

Volumn 30, Issue 3, 2003, Pages 247-251

  Enomoto, Fuyuki ^a   Kin, Ryutaku ^b   Kataoka, Takeshi ^b   Yamazaki, Yoko ^a   Yokoi, Hindenori ^a   Fujimori, Masato ^a   Nagaoka, Isao ^a   Ichikawa, Ginichirou ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Adhesion molecule; Endothelial cell; L Selectin; Mac 1; Neutrophil

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL INFILTRATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; MIDDLE EAR; NEUTROPHIL; NONHUMAN; OTITIS MEDIA; RAT; VASCULAR ENDOTHELIUM;

EID: 0041529972     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(03)00097-X     Document Type: Article

References (16)

1. Enomoto F., Ichikawa G., Nagaoka I., Yamashita T. Effect of erythromycin on otitis media with effusion in experimental rat model. Acta Otolaryngol. Suppl. 539:1998;57-60.
2. Yamaguchi Y., Matsumura M., Takeya M., Ichiguchi O., Kurathu J., et al. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology. 27:1998;727-734.
3. Enomoto F., Ichikawa G., Nagaoka I., Yamashita T. Evaluation of arachidonic acid metabolites in experimental rat otitis media with effusion. Nippon Jibiinnkouka Gakai Zasshi (in Japanese). 98:1998;959-967.
4. Nagaoka I., Yamashita T. Inhibition of the accumulation of macrophages and the generation of macrophage chemotactic activity by dexamethasone in concanavalin A-induced peritonitis of mice. Agents Actions. 25:1988;156-163.
5. Iwabuchi K., Nagaoka I., Someya A., Yamashita T. Type 4 collagen-binding proteins of neutrophils: possible involvement of L-selectin in the neutrophil binding to the type 4 collagen. Blood. 87:1996;365-372.
6. Miyata R., Iwabuchi K., Watanabe B., Sato N., Nagaoka I. Exposure of intestinal epithelial cell HT 29 to bile acids and ammonia enhances Mac-1-mediated neutrophil adhesion. Inflamm. Res. 48:1999;265-273.
7. Shijo H., Iwabuchi K., Watanabe H., Nagaoka I., Sakakibara N. Evaluation of neutrophil function after experimental abdominal surgical trauma. Inflamm. Res. 47:1998;67-74.
8. Tamatani T., Miyasaka M. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int. Immunol. 2:1990;165-171.
9. Vaporciyan A.A., Mulligan M.S., Warren J.S., Barton P.A., Miyasaka M., Ward P.A. Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J. Immunol. 155:1995;1442-1449.
10. Ginis I., Schweiser U., Brenner M., Liu J., Azzam N. TNF-alpha pretreatment prevents subsequent activation of cultured brain cells with TNF-alpha and hypoxia via ceramide. Am. J. Physiol. 276:1999;1171-1183.
11. Takahashi Y., Shimizu T., Sakakura Y. Effects of indomethacin, dexamethasone, and erythromycin on endotoxin-induced intraepithelial mucus production of rat nasal epithelium. Ann. Otol. Rhinol. Laryngol. 106:1997;683-687.
12. Fujita K., Majima Y., Sakakura Y. Effect of macrolides on interleukin-8 secretion from human epithelial cells. Eur. Arch. Otol. 257:2000;199-204.
13. Miyanohara T., Ushikai M., Ueno K., Kinoshita S., Kurono Y. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope. 110:2000;126-131.
14. Lin H.C., Wang C.H., Liu C.Y., Yu C.T., Kuo H.P. Erythromycin inhibits beta2-integrin (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils. Respir. Med. 94:2000;654-660.
15. Rosales C., Juliano R.L. Signal transduction by cell adhesion receptors in leukocytes. J. Leukocyte Biol. 57:1995;189-198.
16. Stein G.E., Havlichek D.H. The new macrolide antibiotics. Azithromycin and clarithromycin. Prostgrad. Med. 92:1992;269-281.